Sublingual Clonidine Dosage
Sublingual clonidine has the same pharmacokinetic and pharmacodynamic profile as oral administration, so use the identical oral dosing: 0.1-0.8 mg daily divided into 2 doses for chronic hypertension, or 0.2 mg initial dose followed by 0.1 mg hourly (maximum 0.7-0.8 mg total) for rapid blood pressure reduction in hypertensive urgencies. 1
Adult Dosing
Chronic Hypertension Management
- Standard dosing range: 0.1-0.8 mg per day, divided into 2 doses 2
- Start with lower doses and titrate upward based on blood pressure response 2
- Clonidine is generally reserved as a last-line agent due to significant CNS adverse effects, especially in older adults 2
Hypertensive Urgencies (Rapid Titration Protocol)
- Initial dose: 0.2 mg, followed by 0.1 mg every hour until goal blood pressure is achieved or maximum total dose of 0.7-0.8 mg is reached 3, 4
- This protocol achieves significant blood pressure reduction in 93% of patients 4
- Mean response time is approximately 1.8 hours with a mean effective dose of 0.32 mg 3
- Alternative initial dosing: 0.1-0.2 mg followed by hourly doses of 0.05-0.1 mg 4
Pregnancy-Specific Dosing
- For hypertension in pregnancy: 0.1-0.3 mg per day in divided doses, up to maximum 1.2 mg per day 2
- Clonidine has been used mainly in the third trimester without adverse outcomes reported 2
Pediatric Dosing
ADHD Treatment (Off-Label)
- Starting dose: 0.05-0.1 mg at bedtime 2
- Titration: Increase by 0.1 mg BID to TID to a maximum of 0.4 mg per day 2
Regional Anesthesia Adjunct
- Preservative-free clonidine: 1-2 micrograms/kg for epidural, caudal, and peripheral nerve blocks 2
- For continuous epidural infusion: 0.2-0.4 micrograms/kg/hour 2
Key Pharmacokinetic Considerations
The sublingual route produces identical absorption characteristics to oral administration—there is no shortened latency or faster onset with sublingual dosing. 1 A study comparing 0.3 mg doses found:
- Half-life, area under the curve, maximum concentration, and time to reach maximum concentration were similar for both routes 1
- Blood pressure and heart rate changes were identical 1
Use sublingual administration when oral intake is not feasible (fasting patients, difficulty swallowing, impaired GI absorption), but expect the same time course of action as oral dosing 1
Critical Safety Warnings
Discontinuation Protocol
- Never abruptly discontinue clonidine—this may induce hypertensive crisis 2
- Clonidine must be tapered gradually to avoid rebound hypertension 2
Common Adverse Effects
- Significant CNS effects including drowsiness and sedation 2
- Dry mouth is common 5
- These side effects are particularly problematic in older adults 2
Monitoring Requirements
- For rapid titration protocols: Monitor blood pressure every hour during titration 3, 4
- Proceed with extreme caution in patients with symptomatic arteriosclerotic disease to avoid precipitating cerebral or cardiac ischemia from excessive blood pressure reduction 3
- Mandatory 24-hour outpatient follow-up for patients treated in emergency settings and discharged 4
Clinical Pitfalls
Avoid using clonidine as first-line therapy—it should be reserved for resistant hypertension or when other agents cannot be used due to its unfavorable side effect profile 2
Do not expect faster onset with sublingual administration—the misconception that sublingual clonidine works more rapidly than oral has been definitively disproven 1
In pregnancy, monitor infants exposed via breastfeeding for drowsiness, hypotonia, and potential seizures—one case report documented these effects with maternal dose of 0.15 mg daily, all resolving within 24 hours of breastfeeding cessation 2